Targeted Temperature Management in Acute Ischemic Stroke

Recruiting N/A Interventional Study
Ischemic Stroke
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
22 (estimated)
Sponsor
Azienda Usl di Bologna · Government
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The goal of this interventional trial is to evaluate whether the CB240\_Aurora medical device is effective for targeted temperature management in adult patients with acute ischemic stroke. The main questions it aims to answer are: Is the CB240\_Aurora effective in maintaining normothermia in patients with acute ischemic stroke? Does the medical device improve clinical and radiological outcomes? Is…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Age \>18 years; * Both sexes; * Diagnosis of acute ischemic stroke confirmed by clinical evaluation by a neurologist and neuroimaging (CT or brain MRI); * Acute ischemic stroke with symptom onset within 48 hours; * Anterior circulation stroke with evidence on neuroimaging (CT …
Contacts

Andrea Zini

+390516478810

a.zini@ausl.bologna.it

CONTACT

Stefano Forlivesi

+390516478889

stefano.forlivesi@ausl.bologna.it

CONTACT